Hepatic Colorectal Metastasis: Current Status of Surgical Therapy

ONCOLOGY

Volumn 12, Issue 10, 1998, Pages 1489-1498

  Fong, Yuman ^a,b   Blumgart, Leslie H ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL TUMOR; CRYOSURGERY; HUMAN; LIVER TUMOR; METASTASIS; PATHOLOGY; PATIENT SELECTION; PROGNOSIS; REVIEW;

CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COLORECTAL NEOPLASMS; CRYOSURGERY; HUMANS; LIVER NEOPLASMS; PATIENT SELECTION; PROGNOSIS;

EID: 0032185502     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 45:8-30, 1995.
2. Bengmark S, Hafstrom L: The natural history of primary and secondary malignant tumors of the liver: I The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23:198-202.
3. Oxley EM, Ellis H: Prognosis of carcinoma of the large bowel in the presence of liver metastases. Br J Surg 56:149-152, 1969.
4. Wood CB, Gillis CR, Blumgart LH: A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285-288, 1976.
5. Bengtsson G, Carlsson G, Hafström L: Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141:586-589, 1981.
6. Klein B, Lu ZY, Gaillard JP, et al: Inhibiting IL-6 in human multiple myeloma. Curr Top Microbiol Immunol 182:237-244, 1992.
7. Baker LH, Talley RW, Matter R, et al: Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs methyl-CCNU plus bolus weekly 5-FU. Cancer 38:1-7, 1976.
8. Grage TB, Vasilopoulos PP, Shingleton WW, et al: Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer. A Central Oncology Group study. Surgery 86:550-555, 1979.
9. Macdonald JS, Kisner DF, Smythe T, et al: 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: Phase II study utilizing weekly 5-FU. Cancer Treat Rep 60-1597-1600, 1976.
10. Buroker T, Kim PN, Grappe C, et al: 5-FU infusion with mitomycin-C versus 5-FU infusion with methyl-CCNU in the treatment of advanced colon cancer. Cancer 42:1228-1233, 1978.
11. Kemeny N, Younes A, Seiter K, et al: Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Cancer 66:2470-2475, 1990.
12. Nordic Gastrointestinal Tumor Adjuvant Therapy Group: Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: A randomized trial. J Clin Oncol 7:1437-1446, 1989.
13. Erlichman C, Fine S, Wong A, et al: A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6:469-475, 1988.
14. Petrelli N, Herrera L, Rustum Y, et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin vs 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 5:1559-1565, 1987.
15. Doroshow JH, Multhauf P, Leong L, et al: Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 8:491-501, 1990.
16. Wagner JS, Adson MA, Van Heerden JA, et al: The natural history of hepatic metastases from colorectal cancer: A comparison with resective treatment. Ann Surg 199:502-508, 1984.
17. Wilson SM, Adson MA: Surgical treatment of hepatic metastases, from colorectal cancers. Arch Surg 111:330-334, 1976.
18. Nordlinger B, Parc R, Delva E, et al: Hepatic resection for colorectal liver metastases. Ann Surg 205:256-263, 1987.
19. Doci R, Gennari L, Bignami P, et al: One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 78:797-801, 1991.
20. Scheele J, Stangl R, Altendorf-Hofmann A, et al: Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13-29, 1991.
21. Rosen CB, Nagorney DM, Taswell HF, et al: Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:492-505, 1992.
22. Fong Y, Blumgart LH, Fortner JG, et al: Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 222:426-437, 1995.
23. Scheele J: Liver resection for colorectal metastases. World J Surg 19:59-71, 1995.
24. Blumgart LH, Fong Y: Surgical management of colorectal metastases to the liver. Curr Probl Surg 5:333-428, 1995.
25. Jaffe BM, Donegan WL, Watson F, et al: Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 127:1-11, 1968.
26. Goslin R, Steele G, Zamcheck N, et al: Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon and rectum. Dis Colon Rectum 25:749-754, 1982.
27. Finan PJ, Marshall RJ, Cooper EH, et al: Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: A clinical and computer analysis. Br J Surg 72:373-377, 1982.
28. De Brauw LM, De Velde CJH, Bouwhuis-Hoogerwerf ML. Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oncol 34:81-86, 1987.
29. Adson MA, Van Heerden JA, Adson MH, et al: Resection of hepatic metastases from colorectal cancer. Arch Surg 119:647-651, 1984.
30. Fortner JG, Silva JS, Golbey RB, et al: Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer: I. Treatment by hepatic resection. Ann Surg 199:306-316, 1984.
31. Butler J, Attiyeh FF, Daly JM: Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 162:109-113, 1986.
32. Pagana TJ: A new technique for hepatic infusional chemotherapy. Semin Surg Oncol 2:99-102, 1986.
33. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 100:278-284, 1986.
34. Cobourn CS, Makowka L, Langer B, et al: Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet 165:239-246, 1987.
35. Schlag P, Hohenberger P, Herfarth C: Resection of liver metastases in colorectal cancer-competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 16:360-365, 1990.
36. Younes RN, Rogatko A, Brennan MF: The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 214:107-113, 1991.
37. Cunningham JD, Fong Y, Shriver C, et al: One hundred consecutive hepatic resections: blood loss, transfusion and operative technique. Arch Surg 129:1050-1056, 1994.
38. Coppa GF, Eng K, Ranson JH, et al: Hepatic resection for metastatic colon and rectal cancer: An evaluation of preoperative and postoperative factors. Ann Surg 202:203-208, 1985.
39. Vogt P, Raab R, Ringe B, et al: Resection of synchronous liver metastases from colorectal cancer. World J Surg 15:62-67, 1991.
40. Morrow CE, Grage TB, Sutherland DER, et al: Hepatic resection for secondary neoplasms. Surgery 92:610-614, 1982.
41. Logan SE, Meier SJ, Ramming KP, et al: Hepatic resection of metastatic colorectal carcinoma. Arch Surg 117:25-28, 1982.
42. Iwatsuki S, Esquivel CO, Gordon RD, et al: Liver resection for metastatic colorectal cancer. Surgery 100:804-810, 1986.
43. Fortner JG, Lincer RM: Hepatic resection in the elderly. Ann Surg 211:141-145, 1990.
44. Smith JW, Fortner JG, Burt M: Resection of hepatic and pulmonary metastases from colorectal cancer. Surg Oncol 1:399-404, 1992.
45. Minnard E, Fong Y, Weigel T, et al: Surgical resection for hepatic and pulmonary colorectal metastases. Proc Am Soc Clin Oncol 15:552, 1996.
46. Divgi CR, Welt S, Real FX, et al: Imaging of hepatic metastases from colorectal carcinoma with 1-131 monoclonal antibody A33. J Nucl Med 30:809, 1989.
47. Adbel-Nabi H, Doerr RJ: Clinical application of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients. Semin Nucl Med 23:99-113, 1993.
48. Doerr RJ, Abdel-Nabi H, Krag D, et al: Radiolabeled antibody imaging in the management of colorectal cancer: Results of a multicenter clinical study. Ann Surg 214:118-124, 1991.
49. Delaloye AB, Delaloye B: Radiolabelled monoclonal antibodies in tumour imaging and therapy: Out of fashion? Eur J Nucl Med 22:571-580, 1995.
50. Findlay M, Young H, Cunningham D, et al: Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumor response to fluorouracil. J Clin Oncol 14:700-708, 1996.
51. Smith FW, Heys SD, Evans NTS, et al: Pattern of 2-deoxy-2-[18F]-fluro-d-glucose accumulation in liver tumours. Primary, metastatic and after chemotherapy. Nucl Med Commun 13:193-195, 1992.
52. Beets G, Penninckx F, Schiepers C, et al: Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer. Dr J Surg 81:1666-1670, 1994.
53. Castaing D, Emond J, Kunstlinger F, et al: Utility of operative ultrasound in the surgical management of liver tumors. Ann Surg 204:600-605, 1986.
54. Vassiliades VG, Foley WD, Alarcon J, et al: Hepatic metastases: CT versus MR imaging at 1.5T. Gastrointest Radiol 16:159-163, 1991.
55. Baron RL, Freeny PC, Moss AA: Computed tomography of the body with magnetic resonance imaging, in Moss AA, Gamsu G, Genant HK (eds): The Liver, chap 17, pp 735-821. Philadelphia, WB Saunders, 1992.
56. Hughes KS, Simons R, Songhorabodi S, et al: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection. Surgery 103:278-288, 1988.
57. Ekberg H, Tranberg KG, Andersson R, et al: Pattern of recurrence in liver resection for colorectal secondaries. World J Surg 11:541-547, 1987.
58. Cady B, McDermott WV: Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 201:204-209, 1985.
59. Nakamura S, Yokoi Y, Suzuki S, et al: Results of extensive surgery for liver metastases in colorectal carcinoma. Br J Surg 79(1):35-38, 1992.
60. Hill DL, Grubbs CJ: Retinoids and cancer prevention. Anna Rev Nutr 12:161-181, 1992.
61. Cady B, Stone MD, McDermott WV, Jr, et al: Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 127:561-569, 1992.
62. Stephenson KR, Steinberg SM, Hughes KS, et al: Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastasis. Ann Surg 208:679-687, 1988.
63. Moertel CG, Fleming TR, Macdonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358, 1990.
64. Maeda T, Hasebe Y, Hanawa S, et al: Trial of percutaneous hepatic cryotherapy: preliminary report [Japanese]. Nippon Geka Gakkai Zasshi (Journal of the Japanese Surgical Society) 93:666, 1992.
65. Hohenberger P, Schlag P, Schwarz V, et al: Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol 44:245-251, 1990.
66. Bozzetti F, Bignami P, Morabito A, et al: Patterns of failure following surgical resection of colorectal cancer liver metastases. Ann Surg 205:264-270, 1987.
67. Marcove RC, Searfoss RC, Whitmore WF, et al: Cryosurgery in the treatment of bone metastases from renal cell carcinoma. Clin Orthop 127:220-227, 1977.
68. Goodie DB, Horton MD, Morris RW, et al: Anaesthetic experience with cryotherapy for treatment of hepatic malignancy. Anaesth Intensive Care 20:491-496, 1992.
69. Moriya Y, Sugihara K, Hojo K, et al: Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: A pilot study. Eur J Surg Oncol 17:519-525, 1991.
70. Curley SA, Roh MS, Chase JL, et al: Adjuvant hepatic artery infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 166:743-748, 1993.
71. Kemeny MM, Goldberg D, Beatty D, et al: Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57:492-498, 1986.
72. Fong Y, Cohen AM, Fortner JG, et al: Liver resection for colorectal metastases. J Clin Oncol 15:938-946, 1997.
73. Bozetti F, Bignami P, Montalto F, et al. Repeated hepatic resection for recurrent metastases from colorectal cancer Br J Surg 79:146-148, 1992.
74. Griffith KD, Sugarbaker PH, Chang AE: Repeat hepatic resections for colorectal metastases. Br J Surg 77:230-233, 1990.
75. Fortner JG: Recurrence of colorectal cancer after hepatic resection. Am J Surg 155:378-382, 1988.
76. Lange JF, Leese T, Castaing D, et al: Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet 169:119-126, 1989.
77. Vaillant JC, Balladur P, Nordlinger B, et al: Repeat liver resection for recurrent colorectal metastases. Br J Surg 80:340-344, 1993.
78. D'Angelica M, Brennan MF, Fortner JG, et al: Ninety-six five year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg, 185:554-559, 1997.
79. Masuda N, Kudoh S, Fukuoka M: Irinotecan (CPT-11): Pharmacology and clinical applications. Crit Rev Oncol Hematol 24:3-26, 1996.
80. Mass GM, Taylor CB: Quantitative hypothermal method for production of local injury of tissue. Arch Pathol 45:563-580, 1948.
81. Ravikumar TS, Steele G, Jr, Kane R, et al: Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res 51:6323-6327, 1991.
82. Ravikumar TS, Kane R, Cady B, et al: A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg 126:1520-1523, 1991.
83. Morris DL, Ross WB: Australian experience of cryablation of liver tumors. Surg Oncol Clin North Am 5:391-397, 1996.
84. Onik G, Rubinsky B, Zemel R, et al: Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma: Preliminary results. Cancer 67-901-907, 1991.
85. Stone MD, Cady B, Jenkins RL, et al: Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg 125:718-721, 1990.
86. Elias D, Lasser P, Hoang JM, et al: Repeat hepatectomy for cancer. Br J Surg 80:1557-1562, 1993.
87. Que FG, Nagorney DM: Resection of "recurrent" colorectal metastases to the liver. Br J Surg 81:255-258, 1994.
88. Fong Y, Cohen AM, Fortner JG, et al: Resection is safe and effective for hepatic colorectal metastases: An analysis of 456 consecutive cases. J Clin Oncol 15(3):938-946, 1997.
89. Nordinger B, Jaeck D, Guiget M, et al: Treatment of hepatic metastases of colorectal cancer, in Nordinger B, Jaeck D (eds): Multicentric retrospective study by the French Surgical Association, pp 129-146, Paris, Springer-Vertag, 1992.
90. Fernandez-Trigo V, Sharmsa F, Sugarbaker PH, et al: Repeat liver resections from colorectal metastasis. Surgery 117:296-304, 1995.